Time course of oxidative events in the hippocampus following intracerebroventricular infusion of quinolinic acid in mice

Neuroscience Research

Volumn 55, Issue 4, 2006, Pages 397-402

  Ganzella, Marcelo ^a   Jardim, Fluvia M ^a   Boeck, Carina R ^b   Vendite, Deusa ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Antioxidant response; Cellular damage; Neurotoxicity; Oxidative stress; Quinolinic acid; ROS formation

Indexed keywords

QUINOLINIC ACID; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN DYSFUNCTION; BRAIN VENTRICLE; CELL DAMAGE; CEREBROSPINAL FLUID; CONTROLLED STUDY; EXCITOTOXICITY; HIPPOCAMPUS; MALE; MOUSE; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PHOTOREACTIVITY; PRIORITY JOURNAL; SEIZURE;

AIDS DEMENTIA COMPLEX; ANIMALS; ANTIOXIDANTS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENCEPHALITIS; FREE RADICALS; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; QUINOLINIC ACID; REACTIVE OXYGEN SPECIES; SEIZURES; TIME FACTORS; UP-REGULATION;

EID: 33744975232     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2006.05.003     Document Type: Article

References (37)

1. Behan W.M., McDonald M., Darlington L.G., and Stone T.W. Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Br. J. Pharmacol. 128 (1999) 1754-1760
2. Boeck C.R., Ganzella M., Lottermann A., and Vendite D. NMDA pre-conditioning protects against seizures and hippocampal neurotoxicity induced by quinolinic acid in mice. Epilepsia 45 7 (2004) 745-750
3. Branna C., Benham C., and Sundstrom L. A method for characterising cell death in vitro by combining propidium iodide staining with immunohistochemistry. Brain Res. Protoc. 10 2 (2002) 109-114
4. Coyle J.T., and Puttfarcken P. Oxidative stress, glutamate and neurodegenerative disorders. Science 262 (1993) 689-695
5. Driver A.S., Kodavanti P.R.S., and Mundy W.R. Age-related in reactive oxygen species production in rat brain homogenate. Neurotoxicol. Teratol. 22 2 (2000) 175-181
6. Evelson P., Travacio M., Repetto M., Escobar J., Llesuy S., and Lissi E.A. Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch. Biochem. Biophys. 388 (2001) 261-266
7. Ferrer I., Blanco R., and Carmona M. Differential expression of active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor following quinolinic acid excitotoxicity in the rat. Mol. Brain Res. 94 (2001) 48-58
8. Goda K., Kishimoto R., Shimizu S., Hamane Y., and Ueda M. Quinolinic acid and active oxygens: possible contribution of active oxygens during cell death in the brain. Adv. Exp. Med. Biol. 398 (1996) 247-254
9. Hempel S.L., Buettner G.R., O'Malley Y.Q., Wessels D.A., and Flaherty D.M. Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2,7-dichloro dihydrofluorescein diacetate, 5 (and 6)-carboxy-2,7-dichloro dihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radic. Biol. Med. 27 (1999) 146-159
10. Heyes M.P., Saito K., Crowley J., Davis L.E., Demitrak M.A., Der M., Dilling R., Kruesei M.J.P., Lackner A., Larsen A.S., Lee K., Leonard H., Markey S.P., Martin A., Milstien S., Mouradian M.M., Pranzatelli M.M., Quearry B.J., Salazar A., Smith M., Sunderland T., Sweedo S., and Tourtellote W.W. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurologic disease. Brain 115 (1992) 1249-1273
11. Heyes M.P., Saito K., and Markey S.P. Human macrophages convert l-tryptophan into the neurotoxin quinolinic acid. Biochem. J. 283 Pt 3 (1992) 633-635
12. Heyes M.P., Achim C.L., Wiley C.A., Major E.O., Saito K., and Markey S.P. Human microglia converts l-tryptophan into the neurotoxin quinolinic acid. Biochem. J. 320 (1996) 590-597
13. Iwahashi H., Kawamori H., and Fukushima K. Quinolinic acid, α-picolinic acid, fusaric acid, and 2,6-pyridinedicarboxylic acid enhance the Fenton reaction in phosphate buffer. Chem. Biol. Interact. 118 (1999) 201-215
14. Lapin I.P. Kynurenines and seizures. Epilepsia 22 (1981) 257-265
15. Lissi E., Pascual C., and Del Catillo M.D. Luminol luminescence induced by 2,2′-azo-bis-(2-amidinopropane) thermolysis. Free. Radic. Res. Commun. 17 (1992) 299-311
16. Lissi E., Salim-Hanna M., Pascual C., and del Castillo M.D. Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free. Radic. Biol. Med. 18 (1995) 153-158
17. Lisy V., and Stastny F. Nitric oxide synthase inhibition and glutamate binding in quinolinate-lesioned rat hippocampus. Physiol. Res. 51 (2002) 299-307
18. Moroni F., Lombardi G., Moneti G., and Aldinio C. The excitotoxin quinolinic acid is present in the brains of several animal species and its cortical content increases with the ageing process. Neurosci. Lett. 47 (1984) 51-55
19. Pellegrini-Giampietro D.E., Cherici G., Alesiani M., Carla V., and Moroni F. Excitatory amino acid release from rat hippocampal slices as a consequence of free radical formation. J. Neurochem. 51 (1988) 1960-1963
20. Perez-Severiano F., Rodriguez-Perez M., Pedraza-Chaverri J., Maldonado P.D., Medina-Campos O.N., Ortiz-Plata A., Sanchez-Garcia A., Villeda-Hernandez J., Galvan-Arzate S., Aguilera P., and Santamaría A. S-allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats. Neurochem. Int. 45 (2004) 1175-1183
21. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83 (1977) 346-456
22. Platenik J., Stopka P., and Vejrazka M. Quinolinic acid-iron (II) complexes: slow autooxidation, but enhanced hydroxyl radical production in the Fenton reaction. Free Radic. Res. 34 (2001) 445-459
23. Qin Z.H., Chen R.W., Wang Y., Nakai M., Chuang D.M., and Chase T.N. Nuclear factor κB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum. J. Neurosci. 19 (1999) 4023-4040
24. Rodríguez-Martínez E., Camacho A., Maldonado P.D., Pedraza-Chaverrí J., Santamaría D., Galván-Arzate S., and Santamaria A. Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum. Brain Res. 858 (2000) 436-439
25. Santamaría A., and Rios C. MK-801, an N-methyl-d-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum. Neurosci. Lett. 159 (1993) 51-54
26. Santamaría A., Jimeénez-Capdeville M.E., Camacho A., Rodriguez-Martínez E., Flores A., and Galván-Arzate S. In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum. Neuroreport 12 (2001) 2693-2696
27. Santamaría A., Salvatierra-Sanchez R., Vazquez-Roman B., Santiago-Lopez D., Villeda-Hernandez J., Galvan-Arzate S., Jimenez-Capdeville M.E., and Ali S.F. Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies. J. Neurochem. 86 (2003) 479-488
28. Schmidt A.P., Lara D.R., Marahin J.F., Perla A.S., and Souza D.O. Guanosine and GMP prevent seizures induced by quinolinic acid in mice. Brain Res. 864 (2000) 40-43
29. Schwarcz R., Foster A.C., French E.D., Whetsell Jr. W.O., and Kohler C. Excitotoxic models for neurodegenerative disorders. Life Sci. 35 (1984) 29-38
30. Schwarcz R., Brush G.S., Foster A.C., and French E.D. Seizure activity and lesions after intrahippocampal quinolinic acid injection. Exp. Neurol. 84 (1984) 1-17
31. Senatorov V.V., Ren M., Kanai H., Wei H., and Chuang D.M. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease. Mol. Psychiat. 9 (2004) 371-385
32. Sriram K., Pai K.S., Boyd M.R., and Ravindranath V. Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice. Brain Res. 749 (1997) 44-52
33. Stone T.W. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45 (1993) 309-379
34. Stone T.W., and Perkins M.N. Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur. J. Pharmacol. 72 (1981) 411-412
35. Tan S., Sagara Y., Liu Y., Maher P., and Schubert D. The regulation of reactive oxygen species production during programmed cell death. J. Cell Biol. 141 (1998) 1423-1432
36. Tavares R.G., Tasca C.I., Santos C.E., Alves L.B., Porciuncula L.O., Emanuelli T., and Souza D.O. Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes. Neurochem. Int. 40 (2002) 621-627
37. Trotti D., Danbolt N.C., and Volterra A. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration. Trends Pharmacol. Sci. 19 (1998) 328-334